[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20052306D0 - Dispergerbare farmasoytiske blandinger. - Google Patents

Dispergerbare farmasoytiske blandinger.

Info

Publication number
NO20052306D0
NO20052306D0 NO20052306A NO20052306A NO20052306D0 NO 20052306 D0 NO20052306 D0 NO 20052306D0 NO 20052306 A NO20052306 A NO 20052306A NO 20052306 A NO20052306 A NO 20052306A NO 20052306 D0 NO20052306 D0 NO 20052306D0
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
dispersible pharmaceutical
dispersible
compositions
pharmaceutical
Prior art date
Application number
NO20052306A
Other languages
English (en)
Other versions
NO20052306L (no
Inventor
Niki Ann Waldron
Nancy Jean Britten
John W Burns
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20052306D0 publication Critical patent/NO20052306D0/no
Publication of NO20052306L publication Critical patent/NO20052306L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0046Ear
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0041Mammary glands, e.g. breasts, udder; Intramammary administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20052306A 2002-12-19 2005-05-11 Dispergerbare farmasoytiske blandinger. NO20052306L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43498502P 2002-12-19 2002-12-19
US10/687,986 US7842791B2 (en) 2002-12-19 2003-10-17 Dispersible pharmaceutical compositions
PCT/US2003/039508 WO2004060345A2 (en) 2002-12-19 2003-12-11 Dispersible pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO20052306D0 true NO20052306D0 (no) 2005-05-11
NO20052306L NO20052306L (no) 2005-07-19

Family

ID=32717791

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052306A NO20052306L (no) 2002-12-19 2005-05-11 Dispergerbare farmasoytiske blandinger.

Country Status (25)

Country Link
US (1) US7842791B2 (no)
EP (1) EP1575618B1 (no)
JP (1) JP3803683B2 (no)
KR (1) KR100752836B1 (no)
CN (1) CN100355457C (no)
AR (1) AR042537A1 (no)
AT (1) ATE336264T1 (no)
AU (1) AU2003296947B2 (no)
BR (1) BR0317104B1 (no)
CA (1) CA2504065C (no)
CY (1) CY1105202T1 (no)
DE (1) DE60307677T2 (no)
DK (1) DK1575618T3 (no)
ES (1) ES2268496T3 (no)
HK (1) HK1081457A1 (no)
MX (1) MXPA05006739A (no)
NO (1) NO20052306L (no)
NZ (1) NZ540715A (no)
PL (1) PL377518A1 (no)
PT (1) PT1575618E (no)
RU (1) RU2311201C2 (no)
SI (1) SI1575618T1 (no)
TW (1) TW200420299A (no)
WO (1) WO2004060345A2 (no)
ZA (1) ZA200504873B (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
BR0314916A (pt) 2002-10-25 2005-08-16 Foamix Ltd Espuma farmacêutica e cosmética
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20050004098A1 (en) * 2003-03-20 2005-01-06 Britten Nancy Jean Dispersible formulation of an anti-inflammatory agent
US20050009931A1 (en) * 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
AU2004258745A1 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible formulation of an anti-inflammatory agent
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
PL1857120T3 (pl) * 2005-01-19 2012-05-31 Nippon Zenyaku Kogyo Co Ltd Infuzje do leczenia zapalenia gruczołów mlekowych
KR100748252B1 (ko) 2006-05-08 2007-08-10 주식회사 삼양애니팜 플로르페니콜 및 타이로신 함유 주사용 조성물
AU2007291308A1 (en) * 2006-08-30 2008-03-06 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2008096918A1 (en) * 2007-02-09 2008-08-14 Kolon Industries, Inc Reactive antibioties and a method of preparing the same and antibacterial fiber treated thereby
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
AU2009271129B2 (en) * 2008-07-14 2013-10-10 Otonomy, Inc. Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CN101804058A (zh) * 2010-04-22 2010-08-18 中国农业科学院兰州畜牧与兽药研究所 一种用于防治奶牛干奶期乳房炎的药物及制备方法
US9409896B2 (en) * 2010-11-01 2016-08-09 Melinta Therapeutics, Inc. Sustained release pharmaceutical compositions comprising an antibacterial agent
CN102058612B (zh) * 2011-01-06 2012-07-04 河南亚卫动物药业有限公司 一种兽用复方乳浊液及其制备方法
WO2013056079A1 (en) * 2011-10-13 2013-04-18 The Johns Hopkins University High affinity beta lactamase inhibitors
KR101352867B1 (ko) 2011-11-07 2014-01-21 주식회사 한동 동물용 복합항생제 조성물
SI2819699T1 (sl) * 2012-02-27 2019-11-29 Bayer New Zealand Ltd Sestavki z nadzorovanim sproščanjem in postopki njihove uporabe
CN103479660A (zh) * 2012-06-14 2014-01-01 符波 一种治疗奶牛临床型乳房炎的乳房注入剂及其制备方法
KR101458611B1 (ko) * 2012-08-02 2014-11-11 주식회사 한동 동물용 복합항생제 조성물
JP6779619B2 (ja) * 2013-02-08 2020-11-04 ルオダ ファーマ リミテッド 乳房炎をはじめとする微生物感染を処置する方法
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
CN106265595B (zh) * 2016-09-29 2019-05-03 甘肃瑞和祥生物科技有限公司 一种肠溶吉他霉素缓释微球及其制备方法
CN106361707B (zh) * 2016-09-30 2019-02-26 广东温氏大华农生物科技有限公司 一种酒石酸泰万菌素颗粒制剂及其制备方法
CN109045044B (zh) * 2018-07-04 2020-11-17 佛山市南海东方澳龙制药有限公司 一种复方药剂及其制备方法、用途
US20220125798A1 (en) * 2019-03-06 2022-04-28 Zoetis Services Llc Ready-to-use injectable formulations
CN112716898A (zh) * 2021-02-22 2021-04-30 青岛康地恩动物药业有限公司 一种替米考星自乳化口服制剂及其制备方法

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA670254A (en) 1963-09-10 E. Gouge Hardin Mastitis composition
US3144386A (en) 1958-05-09 1964-08-11 Merck & Co Inc Mastitis aerosol foam
GB980282A (en) 1960-03-24 1965-01-13 Philips Roxane Antibiotic mastitis composition
US3135658A (en) 1961-10-10 1964-06-02 Merck & Co Inc Non-aqueous oleaginous aerosol foam therapy of bovine mastitis
US3347743A (en) 1964-01-03 1967-10-17 Richardson Merrell Inc Method of treating bovine masititis
GB1089523A (en) 1964-06-25 1967-11-01 Astra Hewlett Ltd Improvements in or relating to veterinary compositions for treating mastitis
GB1181527A (en) 1966-09-21 1970-02-18 Douglas Gabriel Parizeau Composition and Method for Treating Mastitis with Therapeutic Agents.
US3531481A (en) 1969-04-21 1970-09-29 Lilly Co Eli Method for manufacture of crystalline cephalosporin
US3636194A (en) 1969-10-23 1972-01-18 Douglas G Parizeau Composition and method for treating mastitis with therapeutic agents
DE2063896A1 (de) 1970-12-28 1972-07-20 Dynamit Nobel Ag, 5210 Troisdorf Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung
CA1052697A (en) 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
DK154939C (da) 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
US4011312A (en) 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
GB1547164A (en) 1975-08-14 1979-06-06 Beecham Group Ltd Veterinary compositions
GB1589917A (en) 1976-11-27 1981-05-20 Beecham Group Ltd Pharmaceutical composition containing a clavulanic acid derivative
DE2760123C2 (de) 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GB1532682A (en) 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
US4172138A (en) 1977-03-23 1979-10-23 Rhodes Russell E Method and composition of matter for the treatment of dry cows for mastitis
US4104470A (en) 1977-06-03 1978-08-01 Eli Lilly And Company Crystallization process for cefazolin sodium
FR2414509A1 (fr) 1978-01-17 1979-08-10 Glaxo Group Ltd Procede de cristallisation de cefuroxime sodique
SE445174B (sv) 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
US4299501A (en) * 1979-08-10 1981-11-10 Ortho Pharmaceutical Corporation Continuous process for the preparation of semisolid dispersions
FR2479229B1 (fr) 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
NL8002636A (nl) 1980-05-08 1981-12-01 Gist Brocades Nv Solvaat van amoxicilline, werkwijze ter bereiding hiervan en werkwijze ter bereiding van injectiepreparaten uit dit solvaat.
EP0058015A3 (en) 1981-02-05 1982-08-25 Beecham Group Plc Treatment of infections
JPS57134482A (en) 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
US4400503A (en) 1981-10-30 1983-08-23 Eli Lilly And Company Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
JPS58198489A (ja) 1982-05-14 1983-11-18 Meiji Seika Kaisha Ltd 7β−(2D−2−アミノ−2−カルボキシエチルチオアセトアミド)−7α−メトキシ−3−(1−メチル−1H−テトラゾ−ル−5−イル)−チオメチル−3−セフエム−4−カルボン酸ナトリウム塩の七水和物及びその製造方法
YU44680B (en) 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
US4474780A (en) 1983-07-22 1984-10-02 Eli Lilly And Company Crystalline cephalosporin
DE3313818A1 (de) 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
JPS60120886A (ja) 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
US4616080A (en) 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
EP0170623B1 (en) * 1984-08-02 1990-11-28 Sandoz Ag Novel pharmaceutical use of (nva)2-cyclosporine
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
WO1987001117A2 (en) 1985-08-12 1987-02-26 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
IT1190445B (it) 1985-11-08 1988-02-16 Fatro Spa Composizioni veterinarie a base di agenti antimicrobici e loro impiego
HU194493B (en) 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
GB8531609D0 (en) 1985-12-23 1986-02-05 Beecham Group Plc Compounds
NZ220764A (en) 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
US5017380A (en) 1986-07-02 1991-05-21 Shionogi & Co., Ltd. Gelatin hard capsule containing crystalline hydrate of oral cephalosporin
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
GB8621484D0 (en) 1986-09-05 1986-10-15 Norbrook Lab Ltd Intramammary infusion
US4723112A (en) 1986-09-19 1988-02-02 Tektronix, Inc. Level shift circuit for differential signals
GB8629481D0 (en) 1986-12-10 1987-01-21 Beecham Group Plc Veterinary treatment
IT1214587B (it) 1986-12-23 1990-01-18 Giovanni Bonfanti Metodo per la produzione diprodotti cristallini puri.
EP0278656B1 (en) 1987-02-02 1992-06-03 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
AU611461B2 (en) 1987-07-29 1991-06-13 Pharmacia & Upjohn Company Controlled release of antibiotic salts from an implant
US4898938A (en) 1987-08-03 1990-02-06 Rifar S.R.L. Method for preparing crystalline cefadroxil monohydrate
US4877782A (en) 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes
FR2635463A1 (fr) 1988-08-19 1990-02-23 Veprol Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glyceride gelifie par au moins un polymere cellulosique
KR900004323A (ko) * 1988-09-29 1990-04-12 후쿠하라 요시하루 유화 조성물
DE3919259A1 (de) 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
US5143137A (en) 1990-03-08 1992-09-01 Rite-Hite Corporation Overlapping seal for insulated folding door
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5342612A (en) 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
US5314685A (en) 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
ES2079994B1 (es) 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
WO1995031180A1 (en) 1992-12-08 1995-11-23 Bimeda Research And Development Limited A veterinary composition
GB2273443B (en) 1992-12-08 1997-01-08 Bimeda Res Dev Ltd Veterinary composition for the treatment of mastitis
EP0690864B1 (en) 1993-03-12 2001-06-13 PHARMACIA & UPJOHN COMPANY Crystalline ceftiofur free acid
EP1652539B8 (en) 1993-07-19 2011-06-15 Angiotech Pharmaceuticals, Inc. Method of manufacturing a stent comprising an anti-angiogenic composition
US6054136A (en) 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
DE4340781C3 (de) 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
CN1137685C (zh) 1995-06-06 2004-02-11 拜尔公司 无刺激性、无过敏反应、无耳毒性的耳用抗菌组合物
US5736151A (en) 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
JP2002513750A (ja) 1998-05-07 2002-05-14 エラン コーポレーシヨン ピーエルシー 溶媒/助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム
TW537894B (en) 1998-05-26 2003-06-21 Novartis Ag A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist
RU2178293C2 (ru) 1998-08-18 2002-01-20 Панацея Биотек Лимитед Фармацевтическая композиция, содержащая циклоспорин, способ получения мягких желатиновых капсул
US6440964B1 (en) 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
AR020660A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
IT1303793B1 (it) 1998-11-27 2001-02-23 Promefarm S R L "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)"
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
GB9922710D0 (en) * 1999-09-24 1999-11-24 Bayer Ag Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
US20010049366A1 (en) 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid
AU2001261748A1 (en) 2000-05-19 2001-12-03 Alcon Laboratories Inc. Antibiotic compositions for treatment of the eye, ear and nose
JP4738713B2 (ja) * 2000-09-12 2011-08-03 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 修飾された担体を含む医薬組成物

Also Published As

Publication number Publication date
DK1575618T3 (da) 2006-11-13
EP1575618B1 (en) 2006-08-16
PT1575618E (pt) 2006-11-30
CA2504065C (en) 2010-06-29
TW200420299A (en) 2004-10-16
KR20050084416A (ko) 2005-08-26
US7842791B2 (en) 2010-11-30
MXPA05006739A (es) 2005-09-08
EP1575618A2 (en) 2005-09-21
ZA200504873B (en) 2006-04-26
HK1081457A1 (en) 2006-05-19
DE60307677D1 (de) 2006-09-28
NZ540715A (en) 2008-03-28
CN1720065A (zh) 2006-01-11
WO2004060345A2 (en) 2004-07-22
NO20052306L (no) 2005-07-19
AU2003296947B2 (en) 2009-02-19
BR0317104B1 (pt) 2018-01-09
SI1575618T1 (sl) 2006-12-31
ES2268496T3 (es) 2007-03-16
AU2003296947A1 (en) 2004-07-29
DE60307677T2 (de) 2007-08-16
BR0317104A (pt) 2005-10-25
JP2006514955A (ja) 2006-05-18
RU2311201C2 (ru) 2007-11-27
PL377518A1 (pl) 2006-02-06
AR042537A1 (es) 2005-06-22
KR100752836B1 (ko) 2007-08-29
CY1105202T1 (el) 2010-03-03
JP3803683B2 (ja) 2006-08-02
CN100355457C (zh) 2007-12-19
ATE336264T1 (de) 2006-09-15
US20040214752A1 (en) 2004-10-28
RU2005119159A (ru) 2006-01-20
WO2004060345A3 (en) 2004-10-07
CA2504065A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
ITTO20000779A0 (it) Composizioni farmaceutiche.
FI20011478A0 (fi) Farmaseuttinen koostumus
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITTO20010005A1 (it) Formulazione farmaceutica.
NO20052335D0 (no) Dispergerbare defracirox-tabletter
ITMI20010748A0 (it) Composizioni farmaceutiche
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
IS7051A (is) Lyfjasamsetningar
NO20026123L (no) Farmasöytiske sammensetninger
BR0300119B1 (pt) composiÇço aquosa.
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20031095L (no) Farmasoytiske sammensetninger
ITTO20020744A1 (it) Composizione.
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
NL1025908A1 (nl) Farmaceutische combinatie.
NO20044164L (no) Farmasoytiske sammensetninger
MXPA03001857A (es) Composicones medicinales.
ITTO20020745A1 (it) Composizione.
ES1051942Y (es) Canape modular.
NO20043474L (no) Oralt dispersibel farmasoytisk piribedilsammensetning
EE200200689A (et) Ravimkoostised
ITMI20020926A1 (it) Composizioni farmaceutiche riepitelizzanti
ES1053305Y (es) Columbario modular.
DOP2002000508A (es) Composición farmaceutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application